{"id":36726,"date":"2026-03-06T11:44:23","date_gmt":"2026-03-06T11:44:23","guid":{"rendered":"https:\/\/www.vtmarkets.com\/sv\/uncategorized\/cresco-labs-redovisade-en-forlust-per-aktie-pa-002-dollar-i-q4-i-linje-med-prognoserna-medan-intakterna-overtraffade-forvantningarna-pa-arsbasis\/"},"modified":"2026-03-06T11:44:23","modified_gmt":"2026-03-06T11:44:23","slug":"cresco-labs-redovisade-en-forlust-per-aktie-pa-002-dollar-i-q4-i-linje-med-prognoserna-medan-intakterna-overtraffade-forvantningarna-pa-arsbasis","status":"publish","type":"post","link":"https:\/\/www.vtmarkets.com\/sv-eu\/live-updates\/cresco-labs-redovisade-en-forlust-per-aktie-pa-002-dollar-i-q4-i-linje-med-prognoserna-medan-intakterna-overtraffade-forvantningarna-pa-arsbasis\/","title":{"rendered":"Cresco Labs redovisade en f\u00f6rlust per aktie p\u00e5 0,02 dollar i Q4, i linje med prognoserna, medan int\u00e4kterna \u00f6vertr\u00e4ffade f\u00f6rv\u00e4ntningarna p\u00e5 \u00e5rsbasis"},"content":{"rendered":"Cresco Labs Inc. redovisade en justerad f\u00f6rlust p\u00e5 0,02 dollar per aktie i fj\u00e4rde kvartalet (Q4) f\u00f6r kvartalet som slutade i december 2025, i linje med Zacks samlade prognos (konsensus). Ett \u00e5r tidigare var den justerade f\u00f6rlusten 0,01 dollar per aktie.\n\nRapporten visade en resultatavvikelse p\u00e5 +14,16 %. (Resultatavvikelse betyder skillnaden mellan utfallet och marknadens f\u00f6rv\u00e4ntan.) I f\u00f6reg\u00e5ende kvartal l\u00e5g f\u00f6rv\u00e4ntan p\u00e5 en f\u00f6rlust p\u00e5 0,03 dollar per aktie, men bolaget redovisade en f\u00f6rlust p\u00e5 0,05, vilket gav en avvikelse p\u00e5 -66,67 %.\n\nKvartalsint\u00e4kterna uppgick till 161,55 miljoner dollar och var 0,26 % \u00f6ver konsensus. Det kan j\u00e4mf\u00f6ras med 175,91 miljoner dollar samma kvartal \u00e5ret f\u00f6re. Bolaget har slagit int\u00e4ktsprognoserna tre av de senaste fyra kvartalen.\n\nAktien \u00e4r ned cirka 20,7 % hittills i \u00e5r, j\u00e4mf\u00f6rt med en uppg\u00e5ng p\u00e5 0,4 % f\u00f6r S&#038;P 500 (ett brett amerikanskt b\u00f6rsindex). Aktien har Zacks Rank #4 (S\u00e4lj). Branschgruppen Medical &#8211; Products ligger i den nedre halvan bland Zacks 250+ branscher.\n\nNuvarande konsensus pekar p\u00e5 en vinst per aktie (EPS, allts\u00e5 resultat per aktie) p\u00e5 -0,03 dollar p\u00e5 162 miljoner dollar i int\u00e4kter n\u00e4sta kvartal, samt EPS p\u00e5 -0,09 dollar p\u00e5 670,41 miljoner dollar f\u00f6r hel\u00e5ret. Myomo, Inc. v\u00e4ntas rapportera den 9 mars, med prognoser om en f\u00f6rlust p\u00e5 0,09 dollar per aktie (\u00e5r-f\u00f6r-\u00e5r-f\u00f6r\u00e4ndring -800 %) och int\u00e4kter p\u00e5 10,15 miljoner dollar, ned 15,9 %.\n<p>\n\n<p><strong>B\u00f6rja handla nu &#8211; Klicka <a href=\"https:\/\/www.vtmarkets.com\/sv\/trade-now\/\">h\u00e4r<\/a> f\u00f6r att skapa ditt riktiga VT Markets-konto <\/strong> <\/p>\n<!-- \/wp:post-content -->","protected":false},"excerpt":{"rendered":"<p>Sm\u00e5 ljusglimtar i Cresco Labs: Q4-f\u00f6rlust 0,02 dollar per aktie i linje med prognos, men int\u00e4kter sl\u00e5r konsensus. Aktien -20,7% i \u00e5r, Zacks: S\u00e4lj. Prognoser: fortsatt minus.<\/p>\n","protected":false},"author":87,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-36726","post","type-post","status-publish","format-standard","hentry","category-live-updates"],"acf":{"acf_article_selection_author":null},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/posts\/36726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/users\/87"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/comments?post=36726"}],"version-history":[{"count":0,"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/posts\/36726\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/media?parent=36726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/categories?post=36726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/sv-eu\/wp-json\/wp\/v2\/tags?post=36726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}